Addus HomeCare (NASDAQ:ADUS) Given New $142.00 Price Target at Stephens

Addus HomeCare (NASDAQ:ADUS) had its price objective cut by Stephens from $153.00 to $142.00 in a report issued on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock.

Several other equities research analysts have also commented on the stock. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Macquarie restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Oppenheimer boosted their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and an average target price of $132.78.

Addus HomeCare Stock Down 1.0 %

Shares of NASDAQ:ADUS opened at $95.77 on Wednesday. Addus HomeCare has a 52 week low of $87.88 and a 52 week high of $136.72. The company has a 50-day moving average price of $122.60 and a 200 day moving average price of $126.08. The company has a market cap of $1.74 billion, a P/E ratio of 21.92, a PEG ratio of 1.41 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Analysts expect that Addus HomeCare will post 4.59 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ADUS. Capital Research Global Investors purchased a new stake in shares of Addus HomeCare in the fourth quarter valued at $51,149,000. American Century Companies Inc. grew its holdings in Addus HomeCare by 695.8% in the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company’s stock valued at $35,643,000 after buying an additional 248,613 shares during the period. Bank of America Corp DE increased its stake in shares of Addus HomeCare by 273.6% during the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company’s stock valued at $21,945,000 after acquiring an additional 128,211 shares during the last quarter. Wasatch Advisors LP lifted its holdings in shares of Addus HomeCare by 11.8% during the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after acquiring an additional 110,010 shares during the period. Finally, TimesSquare Capital Management LLC boosted its position in shares of Addus HomeCare by 28.5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock worth $44,593,000 after acquiring an additional 78,835 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.